Thyroid cancer risks and medication timing with oral GLP-1s
Like most prescriptions, glucagon-like peptide 1 (GLP-1) medications to manage weight come with potential risks.
Read original article on The Medical News →Related news
-
Immune changes linked to diabetes could guide development of new cancer treatments
United Kingdom
-
ATCC selected by ARPA-H to support next-generation BioStabilization technologies
United Kingdom
-
Your blood pressure could be dangerous even when your numbers look normal
United States
-
Universal immunization of newborns against RSV could significantly reduce infant hospitalizations in EU
United Kingdom
-
Mutated neutrophils may trigger immune attacks in lupus
United Kingdom
-
New microscopy platform enables deeper brain imaging without tissue damage
United Kingdom
-
Soft robotic enteroscope offers a new approach to small intestine examination
United Kingdom
-
Ohio State treats Midwest’s first patient in a trial of novel ventricular tachycardia device
United Kingdom